• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Rathnam Chaguturu joins SRI International

Rathnam Chaguturu joins SRI International

January 30, 2012
CenterWatch Staff

Rathnam Chaguturu, Ph.D., has joined SRI International's Center for Advanced Drug Research (CADRE) as senior director of exploratory research. Chaguturu will partner with SRI's drug discovery and development teams and expand collaborative research relationships with academia, disease foundations, nonprofits and government agencies.

Previously, Chaguturu held director positions at Sierra Sciences in drug discovery and at the University of Kansas in High Throughput Screening Laboratory. He also led discovery research efforts at FMC for more than 20 years, where he was instrumental in designing the industry-first Zymark robotic screening platform for lead discovery.

Chaguturu has authored more than 50 research publications, holds 11 U.S. patents and is editor-in-chief of the journal Combinatorial Chemistry and High Throughput Screening. He is also one of the founding members of the Society for Biomolecular Sciences and the founding president of the International Chemical Biology Society.

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • MAGI East 2023

    MAGI East 2023 Preview: Janssen Reports on Environmental Impact of Trials

  • Complexity-360x240.png

    Phase 3 Trials Significantly Rising in Complexity, Says CSDD

  • Quality Level Scale

    Build Quality into Trials Like You’d Build a House, Says FDA’s BIMO Director

  • DE&I

    Trust-Building, Community Connection Still Essential to DE&I Efforts, Experts Say

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing